The Worldwide Innovative Network(WIN)Consortium in personalized cancer medicine is proud to announce that AstraZeneca,DKFZ and EORTC have joined the Consortium.WIN is a unique global network of leading academics,industries,payors and ...
Tags: WIN, cancer medicine, DKFZ, EORTC
GlaxoSmithKline (GSK) has received FDA approval for Votrient (pazopanib) for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy. The approval is based on the results of the randomized, ...
Tags: advanced soft tissue sarcoma, STS, soft tissue sarcomas, GlaxoSmithKline